SCHEMBL77327

SCHEMBL77327

O=C(Cl)COCCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4740546 0.95 ALDH1A1 (0.30)
SCHEMBL22940138 0.95 ALDH1A1 (0.30)
SCHEMBL4952330 0.85 CES2 (0.32)
SCHEMBL85683 0.84
SCHEMBL25148114 0.82 MEN1 (0.35)
SCHEMBL871278 0.82 MEN1 (0.35)
SCHEMBL21331525 0.80 CES2 (0.38)
SCHEMBL2262348 0.78
SCHEMBL1438928 0.78
SCHEMBL802807 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115806500-A Synthesis of ioversol polysubstituent 大道隆达(北京)医药科技发展有限公司 2023-03-17 CN claimed
CN-114014820-A Preparation method of 4- (4-aminophenyl) -3-morpholinone 南京焕然生物科技有限公司 2022-02-08 CN claimed
WO-2007026041-A2 COMPUESTOS QUINÓNICOS ANTITUMORALES Y SUS DERIVADOS, PROCEDIMIENTO DE OBTENCIÓN Y SUS APLICACIONES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2007-03-08 WO claimed
US-20250368641-A1 QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS INCYTE CORP (US) 2025-12-04 US disclosed
US-12378243-B2 Quinoline compounds as inhibitors of KRAS INCYTE CORPORATION (US) 2025-08-05 US disclosed
US-20250011331-A1 HPK1 ANTAGONISTS AND USES THEREOF SCHRÖDINGER, INC. 2025-01-09 US disclosed
US-20240368152-A1 QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS INCYTE CORPORATION 2024-11-07 US disclosed
EP-4415824-A1 QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS Incyte Corporation (US) 2024-08-21 EP disclosed
CN-118525017-A Quinoline compounds as KRAS inhibitors 因赛特公司 2024-08-20 CN disclosed
EP-4380565-A1 HPK1 ANTAGONISTS AND USES THEREOF Nimbus Saturn, Inc. (US) 2024-06-12 EP disclosed
CN-117915912-A HPK1 antagonists and uses thereof 林伯士萨顿公司 2024-04-19 CN disclosed
US-20050203078-A1 Inhibitors of factor Xa or related serine proteases; thrombosis; benzamide derivatives with benzimidazole, indole or imidazo(1,2-a)pyridine rings; e.g. 4-(azepan-2-on-1-yl)-N-[(1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethyl]-3-methyl-benzamide BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-09-15 US disclosed
WO-2005082895-A1 NOVEL CARBOXAMIDES FOR USE AS XA INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-09-09 WO disclosed
WO-2004087646-A2 PYRROLIDINO-1,2-DICARBOXY-1-(PHENYLAMIDE)-2-(4-(3-OXO-MORPHOLINO-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS FOR USE AS INHIBITORS OF COAGULATION FACTOR XA IN THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GMBH (DE) 2004-10-14 WO disclosed
WO-2004087646-A2 PYRROLIDINO-1,2-DICARBOXY-1-(PHENYLAMIDE)-2-(4-(3-OXO-MORPHOLINO-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS FOR USE AS INHIBITORS OF COAGULATION FACTOR XA IN THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GMBH (DE) 2004-10-14 WO disclosed
US-5628980-A Nonionic radiographic contrast agents BRACCO INTERNATIONAL B.V. (NL) 1997-05-13 US disclosed
US-5614638-A Nonionic radiographic contrast agents BRACCO INTERNATIONAL B.V. (NL) 1997-03-25 US disclosed
US-5591846-A Nonionic radiographic contrast agents BRACCO INTERNATIONAL B.V. 1997-01-07 US disclosed
EP-0431838-B1 Nonionic radiographic contrast agents BRACCO INT BV (NL) 1995-10-25 EP disclosed
EP-0431838-A1 Nonionic radiographic contrast agents BRACCO INTERNATIONAL B.V. (NL) 1991-06-12 EP disclosed